What Researchers Did
Researchers compared photodynamic therapy (PDT) alone to PDT combined with hyperbaric oxygen therapy (HBOT) at two absolute atmospheric pressures (ATA) in 52 patients with advanced esophageal and cardia cancer.
What They Found
Both treatment groups showed similar improvements in swallowing difficulty and the width of the narrowed esophagus. However, the group receiving PDT with HBOT had a significantly greater decrease in tumor length (P=0.002). The mean survival time for patients treated with PDT and HBOT was 13.8 months, which was longer than the 8.7 months for those receiving PDT alone (P=0.021).
What This Means for Canadian Patients
This pilot study suggests that combining HBOT with photodynamic therapy could potentially offer improved outcomes for Canadian patients with advanced esophageal and cardia cancer, specifically by reducing tumor size and extending survival. However, this is not a standard treatment and further research would be needed to confirm these benefits.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a preliminary pilot study with a relatively small number of participants, meaning the findings are not conclusive and require further investigation.